ART Advanced Research Technologies Inc. Appoints DiCamillo to Senior-Level Position of Global Sales & Marketing VP for Preclinical Imaging with Mandate to Implement Direct Commercialisation Strategy for its Optix Imaging System

MONTREAL, CANADA--(MARKET WIRE)--Sep 6, 2007 -- ART Advanced Research Technologies Inc. ("ART") (Toronto:ARA.TO - News), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced that Mr. Dino DiCamillo has joined the Company as an executive officer and Vice President, Global Sales & Marketing, Preclinical Imaging (subject to regulatory approval). With over 20 years of top-level sales, marketing, and customer support experience behind him, Mr. DiCamillo will be leading the overall worldwide preclinical sales and marketing efforts for ART. His primary responsibility will be to develop a strong results-oriented sales team and grow the market share for ART's preclinical products by building direct distribution channels for the Optix® optical imaging system in North America and Europe. Prior to joining ART, Mr. DiCamillo was President of the proteomic technology division of AlfaWassermann, and held executive management positions at Invitrogen Corp., Dynal Biotech LLC. and Applied Biosystems Inc., where he distinguished himself as a top performer in sales revenue generation and in customer support and services.